98 related articles for article (PubMed ID: 31577882)
21. Atrial fibrillation and cancer: prevalence and relative risk from a nationwide study.
Ay C; Grilz E; Nopp S; Moik F; Königsbrügge O; Klimek P; Thurner S; Posch F; Pabinger I
Res Pract Thromb Haemost; 2023 Jan; 7(1):100026. PubMed ID: 36891526
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
[TBL] [Abstract][Full Text] [Related]
23. In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2.
Velayutham S; Seal T; Danthurthy S; Zaias J; Smalley KSM; Minond D
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830718
[TBL] [Abstract][Full Text] [Related]
24. Cancer overdiagnosis: a challenge in the era of screening.
Dunn BK; Woloshin S; Xie H; Kramer BS
J Natl Cancer Cent; 2022 Dec; 2(4):235-242. PubMed ID: 36568283
[TBL] [Abstract][Full Text] [Related]
25. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States.
Liu X; Chen B; Chen J; Su Z; Sun S
J Endocrinol Invest; 2023 Jul; 46(7):1373-1384. PubMed ID: 36522587
[TBL] [Abstract][Full Text] [Related]
26. Melanoma Treatments and Mortality Rate Trends in the US, 1975 to 2019.
Kahlon N; Doddi S; Yousif R; Najib S; Sheikh T; Abuhelwa Z; Burmeister C; Hamouda DM
JAMA Netw Open; 2022 Dec; 5(12):e2245269. PubMed ID: 36472871
[TBL] [Abstract][Full Text] [Related]
27. Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience.
Che W; Liu J; Fu T; Wang X; Lyu J
Curr Oncol; 2022 Nov; 29(11):8374-8389. PubMed ID: 36354720
[TBL] [Abstract][Full Text] [Related]
28. Relative Survival With Early-Stage Breast Cancer in Screened and Unscreened Populations.
Marcadis AR; Morris LGT; Marti JL
Mayo Clin Proc; 2022 Dec; 97(12):2316-2323. PubMed ID: 36336518
[TBL] [Abstract][Full Text] [Related]
29. Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer.
Zhou W; Huang J; Xiao Q; Hu S; Li S; Zheng J; Du Z; Peng J; Chen H
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297485
[TBL] [Abstract][Full Text] [Related]
30. Recent Changes in the Incidence of Thyroid Cancer in Korea between 2005 and 2018: Analysis of Korean National Data.
Choi YM; Lee J; Kwak MK; Jeon MJ; Kim TY; Hong EG; Kim WB; Kim WG
Endocrinol Metab (Seoul); 2022 Oct; 37(5):791-799. PubMed ID: 36220137
[TBL] [Abstract][Full Text] [Related]
31. The burden of prostate cancer in North Africa and Middle East, 1990-2019: Findings from the global burden of disease study.
Abbasi-Kangevari M; Saeedi Moghaddam S; Ghamari SH; Azangou-Khyavy M; Malekpour MR; Rezaei N; Rezaei N; Kolahi AA; ; Amini E; Mokdad AH; Jamshidi H; Naghavi M; Larijani B; Farzadfar F
Front Oncol; 2022; 12():961086. PubMed ID: 36176394
[TBL] [Abstract][Full Text] [Related]
32. Application of nanosonosensitizer materials in cancer sono-dynamic therapy.
Hu C; Hou B; Xie S
RSC Adv; 2022 Aug; 12(35):22722-22747. PubMed ID: 36105955
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Age on Prostate Cancer Survival.
Clark R; Vesprini D; Narod SA
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077685
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of Autopsy Studies.
Arroyo N; Bell KJL; Hsiao V; Fernandes-Taylor S; Alagoz O; Zhang Y; Davies L; Francis DO
J Clin Endocrinol Metab; 2022 Sep; 107(10):2945-2952. PubMed ID: 35947867
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Significance of HER3 Expression in Patients with Cervical Cancer.
Chang CS; Shim JI; Byeon SJ; Lee EJ; Lee YY; Kim TJ; Lee JW; Kim BG; Choi CH
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565268
[TBL] [Abstract][Full Text] [Related]
36. Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease-A National Register Study.
Almdalal T; Sundqvist P; Harmenberg U; Hellström M; Lindskog M; Lindblad P; Lundstam S; Ljungberg B
Eur Urol Open Sci; 2022 May; 39():22-28. PubMed ID: 35528783
[TBL] [Abstract][Full Text] [Related]
37. Population-level Outcomes of Early Thyroid Cancers: A Need to Revisit Current Practice.
Chaturvedi P; Singh A; Bhattacharjee A; Tuljapurkar V; Nair D; Chaukar D; Dikshit R
Rambam Maimonides Med J; 2022 Apr; 13(2):. PubMed ID: 35482460
[TBL] [Abstract][Full Text] [Related]
38. The future of early cancer detection.
Fitzgerald RC; Antoniou AC; Fruk L; Rosenfeld N
Nat Med; 2022 Apr; 28(4):666-677. PubMed ID: 35440720
[TBL] [Abstract][Full Text] [Related]
39. Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis.
Sonbol MB; Mazza GL; Mi L; Oliver T; Starr J; Gudmundsdottir H; Cleary SP; Hobday T; Halfdanarson TR
Oncologist; 2022 Jul; 27(7):573-578. PubMed ID: 35348774
[TBL] [Abstract][Full Text] [Related]
40. Trends in Incidence of Metastatic Prostate Cancer in the US.
Desai MM; Cacciamani GE; Gill K; Zhang J; Liu L; Abreu A; Gill IS
JAMA Netw Open; 2022 Mar; 5(3):e222246. PubMed ID: 35285916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
